2nd Quarter - Report
W STRATEGIES, LLC for GENZYME CORPORATION
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to a regulatory pathway for biosimilars, and provisions related to orphan drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | House Rules Comm Assoc, Subcomm Staff Dir. |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SANOFI SA | United Kingdom | United Kingdom | 100.0% | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| SANOFI SA | Paris FRANCE, GB |
| SANOFI-AVENTIS U.S. INC. | Washington, DC, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.